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KEY POINTS
 Diagnostic tests to identify pathogens involved in respiratory diseases of cattle are
increasingly used, predominantly driven by the need to rationalize antimicrobial use.
 Several methods to sample the respiratory tract are available, of which a deep nasopha-
ryngeal swab, transtracheal wash, and nonendoscopic bronchoalveolar lavage best fit
practice. Each technique has advantages and disadvantages, and consensus regarding
the best choice is not yet reached.
 Next to microbial culture, for microbiologic diagnosis polymerase chain reaction is espe-
cially popular. Promising techniques for a rapid diagnosis are matrix-assisted laser
desorption/ionization time of flight mass spectrometry and next-generation sequencing,
which will become widely available in coming years.
 It is still difficult to interpret identification of opportunistic pathogens, both at the individual
and herd level. More research is needed before evidence-based guidelines can be
developed.INTRODUCTION
In 2012, Fulton and Confer1 warned that the speed of development of new laboratory
diagnostics has outpaced clinicians’ ability to properly interpret test results. A range of
diagnostic tests is now available, ranging from culture to polymerase chain reaction
(PCR) to next-generation sequencing (NGS). However, there is still doubt regarding
the clinical significance of some pathogens detected, and how to interpret a diag-
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Pardon & Buczinski426increasing pressure on antimicrobial use and the need for veterinarians and farmers to
use antimicrobials more rationally.2 The use of diagnostic support by laboratory anal-
ysis is one of the frequently mentioned cornerstones of antimicrobial stewardship
programs.3 However, scientifically reasoned, the evidence that systematic use of lab-
oratory diagnostics, especially the antibiogram, would result in selection of a different
first-choice therapy compared with an empiric decision preferably following (evi-
dence-based) guidelines, is limited, especially in cattle. Antimicrobial resistance in
respiratory tract bacteria from cattle is present and varies highly between systems.
Resistance levels are generally lower in closed dairy and beef herds, substantially
higher in feedlots, and most worrisome in veal calf operations, where oral mass medi-
cation is frequently used.4,5 Although there is no doubt of the presence of resistance,
and multiresistance, in respiratory bacteria from cattle, to what extent this results in
therapy failure when following guidelines for antimicrobial therapy is poorly docu-
mented. In recent years, guidelines specifying first-line, second-line, and third-line
antimicrobial choices for the different cattle diseases have been initiated in several
European Union countries, including the Netherlands, Belgium, Denmark, Sweden,
and Germany.2,6,7 However, the amount of literature reporting the clinical benefit of
every antimicrobial-bacteria combination in highly variable field settings is currently
very limited. Therefore, these guidelines mainly include the spectrum of the antimicro-
bial, pharmaceutical leaflet recommendations and follow classification of the impor-
tance of antimicrobials for human medicine of the World Health Organization.8 In
contrast with human medicine, to the authors’ knowledge there are no extensive,
sufficiently detailed, and large-scale studies available on therapy failure caused by
antimicrobial resistance in cattle.
Regardless of the limitations mentioned earlier, diagnostics are more and more
frequently used when addressing bovine respiratory disease (BRD). This increased
use is understandable, because antimicrobial decision making for BRD still often in-
volves a decision to use group therapy, and, in the current climate, mass medicating
without any evidence of the need for this therapy will increasingly be criticized. The
authors fully acknowledge the complexity of advising on the implementation and inter-
pretation of diagnostic tests for BRD, given the huge gaps in the current knowledge.9
However, the need is urgent, and therefore this article provides a framework to assist
practitioners and clinicians in their everyday decision-making process. This reasoning
may not withstand time; this article does not represent a consensus of all leading ex-
perts, nor is the objective to provide a complete literature overview. This discussion
reflects on the body site sampled, the test used, and the pathogen detected.TYPES OF SAMPLES AND SAMPLING PROCEDURES
The selected sampling site of the respiratory tract is of great importance for interpre-
tation of the test result. Table 1 provides an overview of available sampling tech-
niques, with their advantages and drawbacks. Descriptions of these techniques are
available elsewhere (eg, deep nasopharyngeal swabs [DNSs] and nonendoscopic
bronchoalveolar lavage [nBAL],10 transtracheal aspiration [TTA]/transtracheal wash
[TTW],11 and endoscopic bronchoalveolar lavage [BAL]12; Fig. 1).
Nasal swabs, predominantly sampling the cutaneous part of the nose, are generally
considered of limited value for infectious diagnostics. In contrast, DNSs sample the
respiratory and associated lymphoid epithelium of the nasopharynx and return more
meaningful samples. However, the biggest issue with nasopharyngeal swabs is the
large number of polymicrobial samples recovered (>80%),10 which heavily compro-
mises clinical interpretation when only opportunistic pathogens are retrieved.
Table 1
Overview of available sampling techniques of the respiratory tract of calves and cattle, with advantages and disadvantages
Nasopharyngeal Swab
Transtracheal Wash or
Transtracheal Aspirate
Nonendoscopic Bronchoalveolar
Lavage
Endoscopic Bronchoalveolar
Lavage
Sampling Site Nasopharyngeal mucosa Tracheal bifurcation Individual random lung lobe Individual (or multiple) targeted
lung lobes
Use Single use, disposable Single use, disposable, or
multiple use, sterilizable
Multiple use, sterilizable Multiple use, sterilizable
Representative for
Lower Airways
 Yes Yes, but controversial Yes
Sampled Surface <0.5 cm2 5–10 cm2 >10 cm2 >10 cm2
Procedure Costs  11 1 1111
Estimated Procedure Time
per Animal, Including
Preparation (min)
< 1 10 1–10 10
Contamination Risk from
Nasal Passage
High Absent Moderate (protective sleeve
or agar plug possible)
Low (protective sleeve or agar
plug possible)
Difficulty of the Technique  1 1 11
Possible Complications  Nasal hemorrhage
 Fracture of the swab
shaft
 Subcutaneous emphysema
 Wound infection
 Local hemorrhage
 Accidental tearing of the
catheter by retraction
over the needle and
intratracheal loss of the
remaining part
 Respiratory distress caused
by insufficient aspiration
of instilled fluid
 Nasal hemorrhage
 Intrapulmonary hemorrhage
 Airway perforation (rigid
catheter only)
 Respiratory distress caused
by insufficient aspiration of
instilled fluid
 Nasal hemorrhage
 Respiratory distress caused by
insufficient aspiration of
instilled fluid
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Fig. 1. Overview of accessible sampling methods of the airways in cattle. (A) DNS, (B) TTW,
(C) nBAL through the mouth under visual control; (D) nBAL performed blindly through the
nose.
Pardon & Buczinski428Contamination can be reduced by rinsing the nares (with a single-use paper towel or a
gauze with alcohol) or by using a guarded DNS. However, studies specifically focusing
on the effect of guarded swabs to reduce nasal contamination are, to the authors’
knowledge, not available in cattle. Recent reports on the respiratory microbiome in
cattle also put the idea of contamination at that sampling site into another perspective,
given the large variation in bacterial species normally present.13,14 The largest disad-
vantage of DNSs is that they do not directly sample the lower respiratory tract. Despite
some conflicting results, previous studies overall showed that, for most pathogens, an
association between DNS results and TTW or BAL is present.10,15–17 In addition to
cotton swabs, brush swabs also exist, which cause more intensive swabbing of the
mucosa (although possibly also blood staining of the sample), presumably with higher
detection rates. No evidence on their benefit for use in cattle is currently available.
Complications of DNS are rare and included nasal hemorrhage and fracture of the
shaft of the swab. The latter is without any harmful consequence because the animal
evacuates the remaining part of the swab either by sneezing or swallowing.
To overcome the issue of nasal contamination, transtracheal sampling techniques
relying on perforation of the trachea with a needle or catheter after surgical preparation
of the skin have been developed. Historically, transtracheal swabs have been used,18
but the transtracheal aspirate and wash are now common. Although an aspirate (TTA)
only involves aspiration of mucus present in the respiratory tract, a wash (TTW) re-
quires fluid instilment and immediate aspiration. Despite the terminology TTA being
frequently used in the field, the technique usually used is a TTW. Most frequently,
for TTW in cattle, TTW kits (Large Animal Trans-Tracheal Wash Kit, MILA International,
Inc, Florence, KY), or human central venous catheters (eg. Centracath 75, Vygon,
BRD Diagnosis 429Ecouen, France) are used, which are commercially available and sterile packed for sin-
gle use. Alternatively, a male dog urinary catheter can be used in combination with a
12-G catheter/needle to perforate the trachea in between 2 tracheal rings.19
In veterinary medicine, the common thinking is that the TTW is preferred for bacte-
riology and BAL to study inflammation (cytology). However, this recommendation
generally comes from horse medicine, and seems to be expert opinion rather than
supported by substantial peer-reviewed studies.20 In humans, TTW is generally not
used for ethical reasons. The general idea is that the bronchial bifurcation is the site
where the efflux of the mucociliary system of the whole of the lung comes together.
Hence sampling there would be representative for the whole of the lung.20 However,
there are some counterarguments for this reasoning. First, the mucociliary system can
be heavily impaired by pneumonia. Second, microbial aspiration from the naso-
pharynx into the upper trachea is likely frequent. Third, normal pathogenesis involves
gradual descent of bacteria down the respiratory tree toward the lung. Taking the sec-
ond and third arguments into account, a positive TTW culture might equally represent
a bacterial tracheitis or even an insignificant colonization or upper airway contamina-
tion, resulting in false positive diagnosis of infectious bronchopneumonia. Advantages
are that a new disposable catheter can easily be used for each animal, and sampling is
theoretically achievable within a predictable time frame given that no active coopera-
tion of the animal is required, in contrast with BAL. However, sedation of the animal
and local anesthesia of the puncture site can be done to improve animal comfort dur-
ing the procedure.
In a BAL procedure, a BAL catheter or flexible endoscope is introduced through the
nose and trachea into the lower airways until it wedges into a larger (or smaller
depending on catheter diameter) bronchus. Next, while holding in this wedged posi-
tion, a volume (usually 60 mL in calves, if necessary followed by a second or third in-
jection) of sterile saline is injected and immediately aspirated. Classically, as in human
medicine, a BAL is performed by endoscopy. The major advantage is that a specific
lung lobe, previously shown to be affected on radiology or ultrasonography, can be
sampled. Also, protective sheets or agar plugs can be used to reduce the risk of nasal
contamination. The major disadvantage of the endoscope is the high operating costs
and risk for equipment damage in the farm setting. Also, sampling multiple animals be-
comes difficult because time to resterilize the endoscope between animals is needed
(15–20 minutes minimum).
To overcome the cost and risks of endoscopic BAL, nBAL techniques have been
developed. In nBAL, a BAL catheter is blindly introduced through the nose, larynx,
and trachea until the wedged position in a large bronchus is reached. Next, a volume
of saline is injected and gently aspirated. The volume used varies substantially be-
tween studies (30–250 mL16,17), but a trend to reduce the volume for welfare/comfort
reasons is present.21 On average, 33.5% of the volume (12.0%–73.8%) can be recov-
ered in nBAL, which is substantially larger than in a TTW procedure.21 It is important to
realize that sedation not only suppresses the required responses (coughing, curving of
the nose, and extroversion of the tongue) to ensure an intratracheal position but also
causes systematic sampling of the diaphragmatic lung lobes, which are less likely to
be affected.22 Good restraint of the calf with the head fixed with the nose pointing up-
ward as much as possible is advisable to ease blind introduction of the tube into the
trachea. Alternatively, the calf might be surprised into allowing the tube to be
advanced into the airways by placing the head in a horizontal position, and introducing
the catheter on inspiration visible by the opening of the nostrils. Overall, in 80% of an-
imals, nBAL sampling can be completed within minutes. For the remaining 20%, the
practical advice is to select another animal to sample when undertaking group
Pardon & Buczinski430diagnosis, rather than spending excessive time and causing prolonged irritation to a
reluctant animal. Alternatively, a technique where a double-guarded BAL catheter is
orally introduced into the larynx through a PVC (polyvinyl chloride) speculum has
been described for calves that are at least 3 to 4 months old, where the guarded cath-
eter is inserted through the larynx under visual control.23
The use of BAL samples (especially nBAL) for bacteriology is still highly controver-
sial, mainly because of the risk of nasal contamination. Although contamination is far
less than with DNS, 20.8% of nBAL samples were still polymicrobial.10 A large influ-
ence of the sampler seems to be present,10 likely depending not only on differences
in hygienic sample handling but also on skills to swiftly introduce the catheter without
touching too much of the nasopharynx. However, it is important to realize that hard
evidence on substantial nasal contamination by using nBAL catheters is currently
not available in any species. The only available study on this matter showed pure cul-
ture and negative results in 29.2% and 40.3% of the nBAL samples, even though DNS
samples of the same animals were polymicrobial.10 Further, the currently most exten-
sive study on sample method comparison showed very good agreement for bacteri-
ology between DNS, TTW, and nBAL.17 Interestingly, in human medicine, there are
growing efforts toward the use of a mini-BAL procedure for bacterial diagnosis in
ventilator-assisted pneumonia.24 Overall, sample contamination should be avoided
and, in the case of nBAL, this can be done by adequate training or visualization of
the larynx by a video speculum (Ivetscope, Dairymac Limited, Hampshire, United
Kingdom) or endoscopic cameras intended for plumbers or auto mechanics. These
devices are available at much lower prices than traditional endoscopes.
Next to the site of the respiratory tract sampled (upper or lower airway), the cultural
perception of the effect of the sampling technique on animal welfare also plays an
important role in what technique is currently preferred in a given country/region. No
studies on the effect of respiratory tract sampling on stress or pain have yet been con-
ducted in calves. A Master of Science thesis showed that both animals sampled by
DNS or nBAL spent less time walking compared with the unsampled control group,
whereas lying or eating were unaffected.25 For TTW as well as nBAL, the required vol-
ume of saline to be instilled is unclear; it is also unclear whether the volume instilled
influences bacteriology results, as it does for cytology.26
In summary, sampling techniques for the field need to be economically feasible both
in terms of equipment/disposables cost and also invested time. The DNS, TTW, and
nBAL best suit this profile and are currently most frequently used in the field. Differ-
ences in use exist between countries, which mainly originate from historical or cultural
preference.AVAILABLE DIAGNOSTIC TESTS FOR THE CAUSAL DIAGNOSIS OF BOVINE
RESPIRATORY DISEASE
An overview of available diagnostic tests for pathogen identification in respiratory dis-
eases in cattle is shown in Table 2. It is beyond the scope of this article to provide a
complete overview of all tests possible. The focus is on the most frequently used tests
and the most promising future tests likely to become widely available for practice
within the next 5 years. In the current international context, the pressure to reduce
antimicrobial use has become the main driver of diagnostic test performance for
causal diagnosis of BRD. A crucial aspect for field efficacy is a short turnaround
time (TAT), the time between sampling and availability of the test result. In order to
be able to use the diagnostic test result to target therapy or initiate control measures
TAT needs to be as short as possible, ideally less than a day. However, having test
Table 2
Advantages and disadvantages of available diagnostic tests to detect bacterial pathogens involved in respiratory disease in live cattle
Use Turnaround Time* Advantages Disadvantages
Microbial Culture Live bacteria
detection
 24 h to 3 d for
Pasteurellaceae
 >5 d for Mycoplasmata
 Cheap
 Evidence of live pathogen
 Quantification possible
 Antibiogram possible
 Live organisms needed
 More time consuming
 Lower sensitivity
 Fastidious growers (eg, Histophilus somni) more
easily overgrown (false-negatives)
 Specific media needed for certain pathogens
(eg, mycoplasmata)
PCR DNA detection
(specific
genomic
region)
 24 h  Very high sensitivity
 No live organisms required
 Limited effects of
contaminated samples
 Pooling of samples possible
 Quantification possible (qPCR)
 Possible detection of insignificant quantities or
dead bacteria (high sensitivity)
 Possible detection vaccine antigen (false-positive)
 More expensive
Serology
(Antibody ELISA)
Antibody
detection
 Variable (24 h to 1 wk)
depending on
laboratory routine
 3 wk for paired sera
 Longer time frame for
pathogen detection
 Both infection as
vaccination status
 Indirect evidence of infection
 Variable, but generally lower sensitivity and
specificity
 Results require 3 wk (paired sera)
 No differentiation vaccine induced antibodies
from natural infections
Culture-enriched
Direct MALDI-TOF
Live bacteria
detection
 6 h for Pasteurellaceae
 3 d for Mycoplasmata
 Cheap (cost comparable
with culture)
 Rapid
 Antibiogram possible with
MBT-ASTRA
 MALDI-TOF required
 Lower diagnostic accuracy in polymicrobial or
mixed culture samples
Nanosequencing DNA detection
(whole
genome)
 Possible within 1–2 d  All possible pathogens
simultaneously detected
and quantified
 Strain typing possible
 No classic antibiogram possible
 More expensive
* Turnaround time is the time between arrival in the laboratory and availability of the test result. Reported times are in optimal conditions.
Abbreviations: ELISA, enzyme-linked immunosorbent assay; MALDI-TOF, matrix-assisted laser desorption/ionization time of flight; MBT-ASTRA, MALDI Biotyper
Antibiotic Susceptibility Test Rapid Assay; qPCR, quantitative PCR.
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Pardon & Buczinski432results the next morning might also be workable for most outbreaks. Also, the use of
cow-side testing for a causal diagnosis of BRD has great potential to reduce TAT.
However, to the authors’ knowledge, no such tests are currently commercially avail-
able. Hence, attention should be given to ensuring proper and timely transport to
the laboratory. At refrigerator temperature (4C–8C), the isolation rate ofMannheimia
haemolytica and Pasteurella multocidawas not reduced for 24 hours, whereas a trans-
port temperature of more than 30C resulted in reduced isolation as soon as 2 hours
later.27
Serology
Serologic tests are useful to target vaccination programs, to determine protective sta-
tus, and to evaluate infection dynamics at larger scale. However, they are not suitable
to direct immediate therapy because they have a TAT of 3 weeks (required time for
seroconversion) and only provide indirect evidence of infection. Also, for the opportu-
nistic Pasteurellaceae family, maternal immunity smoothly shifts to acquired immunity,
without any signs of disease or seroconversion.28 Another important issue is that
sensitivity and specificity can be highly variable between different antibody enzyme-
linked immunosorbent assays (ELISAs), hampering clinical interpretation and their
use for individual animal decisions (eg, culling or purchase).29 For targeting therapy,
direct identification of the pathogen is needed, and this can be achieved by microbial
culture, matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) mass
spectrometry (MS), PCR, or NGS/third-generation sequencing.
Microbial Culture
Microbial culture is most frequently used for identification of bacteria. Next to low
operating costs, the possibility of antimicrobial susceptibility testing is an important
advantage of culture. For mycoplasmata, specific media are required,29 and fastidious
growers, especiallyHistophilus somni, are easily overgrown, resulting in false-negative
results.10,30 Sensitivity and specificity of microbial culture have not been determined
for most of the bacteria involved in BRD. A recent study using bayesian latent class
analysis showed that Mycoplasma bovis culture on solid medium containing Tween
80 is 70.7% (95% bayesian credible intervals [BCI], 52.1 to 87.1) sensitive and
93.9% (95% BCI, 85.9–98.4) specific.31
Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry
In the last decade, MALDI-TOF MS, which identifies bacteria by their unique protein
profiles, has revolutionized routine diagnostics. It is primarily used for identification
of bacteria after culturing, including Mycoplasma species.32 However, MALDI-TOF
MS can also be applied directly on the sample after a very short period of enhanced
growth in a liquid medium. Relative to classic microbial culture, these culture-enriched
direct MALDI-TOF MS techniques allow correct bacterial identification in 73% of
the samples (sensitivity 5 59.1%; 95% confidence interval [CI], 47.2–71.0; speci-
ficity 5 100% [100–100]) within 6 hours.33 The technique performed less well in
polymicrobial samples and in samples with mixed infection. Also for M bovis, a
culture-enriched direct MALDI-TOF MS technique was developed, which was
86.6% (95% BCI, 54–99) sensitive and 86.4% (95% BCI, 80–96) specific in a bayesian
latent class model including PCR and microbial culture on solid agar.31 TAT was
reduced from more than 5 days to less than 3 days.31 In addition, different MALDI-
TOF MS methods are available for antimicrobial susceptibility testing. By means of
MBT-ASTRA (MALDI Biotyper Antibiotic Susceptibility Test Rapid Assay), oxytetracy-
cline resistance in P multocida could be identified with high accuracy (Se 5 95.7%;
BRD Diagnosis 43395% CI, 86.3–100.6; Sp 5 100%; [95% CI, 100–100]) in as little as 3 hours, outper-
forming the disc diffusion antibiogram.34 The MBT-ASTRA technique can be designed
for every bacterium-antibiotic combination, but logistical changes are needed to
create a good intralaboratory workflow. The costs of MALDI-TOF procedures are
generally low, in line with microbial culture.
Polymerase Chain Reaction
PCR for the causal diagnosis of BRD is now very popular. The main reasons are that
multiplex PCR or multiple single PCRs allow detection of multiple bacteria and viruses,
providing practitioners with a more extended view of the pathogens involved and
hence more options to better target therapy, control, and prevention. Fastidious
and metabolically active viable but unculturable viruses and bacteria can be detected,
in contrast with standard microbial culture.35 However, in contrast with sequencing
techniques, specific primers are needed, and the pathogen of interest needs to be
determined beforehand. In this way, the diagnostics are potentially biased and
possibly lead to false-negative results. Another problem is that viral genomes evolve
rapidly and primers might become outdated, limiting the efficient detection of the
pathogens of interest. PCR is generally not cheap, but, by pooling samples (DNS,
TTW, or BALs), a group diagnosis can be reached and costs are decreased. In avail-
able studies, pools of samples from 5 animals were shown to improve diagnostic ac-
curacy at the group level.36,37 The largest disadvantage of PCR is interpretative
difficulty, because PCR can identify dead pathogens, opportunists currently not
involved in infection, and contaminants, none of which signify a clinically meaningful
test result. This disadvantage was shown, for example, for H somni.19 The use of
quantitative PCR is more informative because the pathogen load, especially in the res-
piratory disease complex, is important to consider. For this reason, quantitative PCR is
increasingly used in veterinary laboratories, although interpretative questions remain.
Especially, when multiple pathogens are detected, determining the attributable frac-
tion of each pathogen to the clinical presentation remains very difficult.38
Next-Generation and Third-Generation Sequencing
NGS technologies are now becoming more widely available because of the democra-
tization of the technologies, and because platforms such as MinION (Oxford Nanopore
Technologies, Oxford, UK) allow decentralized sequencing experiments. The first
studies using NGS (metagenomics) to detect viruses involved in BRD in feedlots are
already reported; these detected known pathogenic viruses as well as previously un-
known or incompletely understood viruses (eg, influenza D virus).39,40 Hence, the
advantage of NGS is that all pathogens can be simultaneously detected, without prior
selection of which pathogens to test for. Also, semiquantitative results can be reported
because, for most viruses, the number of reads corresponds to the initial load of the
pathogen present.41 Not only viruses but also whole genomes can be recovered at
a scale that is constantly increasing. Eventually, direct sequencing of bacteria will
allow detection of virulence genes, phylogenetic clustering of strains during out-
breaks, and ultimately prediction of antimicrobial resistance based on single nucleo-
tide polymorphisms or resistance genes. A high total bacterial burden and low
bacterial community diversity were associated with positive culture results in classic
microbial culture.35 NGS is the basis for microbiome studies, which are discussed
elsewhere in this issue.42 Disadvantages are that NGS is costly and requires a long
TAT under the current conditions using the most accurate devices (eg, Illumina, San
Diego, CA). However, with nanopore sequencing platforms (eg, MinION) a higher
throughput and shorter TAT can be achieved. This long-read technology has been
Pardon & Buczinski434commercially available since 2014 and has made tremendous improvements in output
and accuracy. In humans and pigs, MinION has been used to characterize pathogens
in different types of samples, even at the site of disease outbreaks, because data anal-
ysis can be done in the field on portable hardware.43,44 On human lower respiratory
tract samples, within 6 hours of sampling, a result was given at a sensitivity of
96.6%.45 However, in order to achieve wide implementation in veterinary practice,
the cost, the ability to correctly interpret, and setup of an actionable logistic chain
will be essential. Therefore, this technology is another case in which analysis of pooled
samples from multiple animals to obtain a group diagnosis of primary pathogens will
be the most likely application.INTERPRETATION OF DIAGNOSTIC TEST RESULTS AND SAMPLING STRATEGY
Clinical interpretation of a diagnostic test result to determine the infectious cause of a
respiratory tract disease requires information on the pathogen identified, the site of the
respiratory tract sampled, the diagnostic test used, the clinical condition of the animal,
and whether the sample originates from a single animal or is pooled. There is no cur-
rent consensus on the way to sample the respiratory tract or to interpret diagnostic
test results in humans and many other species. Based on the available research, it
is unlikely that an evidence-based consensus on respiratory tract sampling method,
diagnostic testing, and interpretation of results in cattle can be reached. Hence, this
article assists readers to properly interpret results of testing by providing information
not only on current recommendations but especially on the drawbacks and research
gaps.
Detection of Primary Pathogens
The first point to consider is the nature of the pathogen retrieved, whether it is a pri-
mary or secondary pathogen. A primary or obligate pathogen (when present), per defi-
nition, induces damage to the respiratory tract, mostly followed by an inflammatory
response. However, depending on the infectious dose and host immunity, infection
might result in clinical disease or not. Also, certain primary pathogens can chronically
and even asymptomatically infect animals, resulting in carriers: for example, Salmo-
nella spp orM bovis. Most primary pathogens weaken innate immunity of the airways,
facilitating superinfection by opportunistic bacteria. Some, such as bovine respiratory
syncytial virus, bovine herpesvirus type 1 (BHV-1), and potentially also others
(Table 3), are able to induce life-threatening disease without bacterial superinfection.
Despite still being controversial in some scientific communities or countries,Mbovis is
generally considered a primary pathogen.46 Detection of a primary pathogen can, with
some caution, be interpreted straightforwardly. The primary pathogen should normally
not be present, and, depending on its virulence, it can, either as a sole agent or in com-
bination with other agents, be held responsible for the clinical picture. Also, detection
from any site of the respiratory tract is meaningful. For animal welfare reasons and
following the pathogenesis, which starts with nasal infection, DNS samples might
be sufficient and even most appropriate to detect primary pathogens. However,
detection rates at the different sites of the respiratory tract differ between pathogens.
For bovine coronavirus, DNS was more frequently positive than samples from the
lower respiratory tract, whereas the inverse was true for bovine respiratory syncytial
virus.17 For BHV-1, DNS is recommended given that the infection most frequently re-
mains limited to the upper airways. The true interest of any diagnostic effort lies in
extrapolation of test results from the sampled animals to the whole group. Detection
of primary pathogens in some animals makes involvement of the same pathogen in the
Table 3
Overview of viruses and bacteria commonly isolated from samples of the respiratory tract in cattle
Pathogen
Primary or Secondary
Pathogen Remarks Reference
Bovine adenovirus Primary, but
controversial
Widespread, but generally mild disease, except immunocompromised calves
(types 3, 4, and 7)
Type 10 associated with lethal enteritis
58–61
Bovine coronavirus Primary, but
controversial
As a sole agent, experimentally only able to induce mild disease. Outbreaks
with single viral infection resulting in severe morbidity and mortality
described in calves and adult cattle
62,63
BHV-1 Primary Limited to the nasal cavity, pharynx, and trachea. Immunosuppression by
hampering function and number of white blood cells. Potentially lethal as
a single agent
62
Bovine rhinitis virus A and B Likely apathogenic — 39
Bovine respiratory syncytial virus Primary As a single viral agent, able to cause lethal bronchopneumonia. In older
animals frequently subclinical
52,62
Bovine viral diarrhea virus Primary Mainly immunosuppression by hampering function and number of white
blood cells. Potentially lethal as a single agent
62,64
Parainfluenza virus type 3 Primary As a single agent, generally mild disease 52,62
Influenza D virus Controversial, likely
primary
As a sole agent, experimentally only able to induce mild disease.
Epidemiologically linked with disease
39,65
Bibersteinia trehalosi Secondary Occasionally isolated from cattle. More pathogenic role attributed to this
bacterium in sheep
66
Histophilus somni Controversial, likely
secondary
Part of the resident flora. Septicemia is a lethal complication resulting in
myocarditis, polyserositis, and thrombotic meningoencephalitis. Risk
factors of septicemia unclear
52
Mannheimia haemolytica Controversial, likely
secondary
Part of the resident flora, differences in strain virulence described possibly
resulting in some primary pathogenic strains. Other studies show cattle to
become ill from their own resident strain on exposure to other pathogens
and/or risk factors
11,49,52
Chlamydia psittaci Controversial, likely primary Natural infections result in mild or subclinical disease 75
(continued on next page)
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Table 3
(continued )
Pathogen
Primary or Secondary
Pathogen Remarks Reference
M bovis Primary Extended immunosuppressive effect on white blood cells combined with
immune-evasive mechanisms resulting in chronicity. Clonal spread of a
strain limited in time and space is the general rule
46,47
Mycoplasma bovirhinis Apathogenic — 19
Mycoplasma dispar Controversial, likely
apathogenic
Recently shown to be more part of the microbiome of feedlot cattle
classified as healthy
14,19,67
Moraxella bovis/ovis Secondary Primary eye pathogen, occasionally isolated in pure culture from animals
with bronchopneumonia
68
Pasteurella multocida Secondary Part of the resident flora. Strain virulence differences exist, and some disease
presentations (eg, septicemia or peritonitis) have been linked to certain
strains
52,69
Salmonella spp Primary Primary site of infection of most Salmonella spp is the gastrointestinal tract.
Localization in the respiratory tract is possible, most likely after septicemic
spread
70
Trueperella pyogenes Secondary Involved in purulent processes. Often regarded as characteristic for
chronicity. However, naturally resistant to fluoroquinolones
71
Escherichia coli, Gallibacterium
anatis, Enterobacter hormaechei,
staphylococci, streptococci, fungi
Secondary Single reports on cattle-specific strains isolated in pure culture in an
outbreak of pneumonia in calves
52,72–74
Multiple other bacterial species can be detected in the bovine respiratory tract. This table is limited to either known primary pathogens or frequently isolated
pathogens, currently assumed to have a pathogenic significance.
Data from Refs.11,14,19,39,46,47,49,52,58–74
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BRD Diagnosis 437cohoused animals very likely.47 Hence, to improve sensitivity of the group diagnosis,
the use of PCR on a pooled sample (up to 5 animals) can be considered.36,37 A pitfall
when working with PCR to detect primary pathogens is that vaccine antigen can be
detected up to 14 days after intranasal vaccination with a live vaccine, resulting in
false-positives.48
Detection of Secondary Pathogens
A secondary or opportunistic pathogen can be part of the normal respiratory micro-
biome, without inducing inflammation. In general, breaching of innate immunity, either
by another pathogen or a noninfectious cause, is needed before the opportunistic
pathogen invades tissues and induces inflammation. Interpretation of detection of
an opportunistic pathogen is more difficult, given that they can be present in healthy
animals.10,16,19 Therefore, simply detecting the pathogen cannot be seen as evidence
of its involvement. The Pasteurellaceae family and a range of other bacteria (eg, Strep-
tococcus spp and Trueperella pyogenes) are generally considered secondary patho-
gens. Although there seems to be little discussion of P multocida, scientific opinions
on the potential primary role and differences in strain virulence of M haemolytica
and H somni vary greatly.11,49 It is outside the scope of this article to review or take
a position on this matter. Similarly, in other species, including humans, this issue of
opportunistic pathogens exists. When interpreting a positive culture result, a differen-
tiation between contamination, colonization, and infection needs to be made.
Contamination is defined as the presence, usually in low numbers, of bacteria in a
sample that are not expected to be present in the sampled site. Colonization can be
defined as the presence of a micro-organism in a host, with growth and multiplication
of the organism, but without interaction between host and organisms, hence no in-
flammatory reaction, immune response, or clinical expression occurs.50 Similarly,
infection is isolation of a high number of bacteria from a site of the respiratory tract,
but in the presence of inflammation of the mucosa, presenting either clinically or sub-
clinically.50 Hence, simply picking a suspected colony from an agar plate, to confirm
the cause of the respiratory disease, and subsequently using an antibiogram based on
this single colony may be misleading. More information can be derived from culture
results if quantitative descriptions and at least the degree of contamination are
described. A possible way to better describe culture results, previously used for
research purposes,10,33 is presented in Table 4. It is also important to realize that us-
ing selective media for Pasteurellaceae, as, for example, by adding bacitracin, ensures
better growth and detection of these opportunistic pathogens, but information on the
amount of pathogens and degree of contamination of the sample will be lost.5,51
Pasteurellaceae are part of the normal respiratory flora, and can even be abundantly
present in the nasal cavity of healthy animals.52 An association between the presence of
a Pasteurella species in the nose and its presence in the lower respiratory tract is
described.10,15,16 However, interpretation of DNS results for opportunistic pathogens
remains very difficult, especially because the composition of the nasopharyngeal micro-
biota seems to be heavily influenced by bioaerosols from the agricultural environment.53
Loss of biodiversity and overgrowth of opportunistic pathogens occurs in the pathogen-
esis of BRD, resulting in higher odds that Pasteurellaceae can be cultured from nasal
swabs in larger quantities in ill animals.10,35,54 However, with current knowledge on
the interpretation of DNS results at the individual or group level, samples of the lower
respiratory tract are likely a better option to evaluate potential involvement of opportu-
nistic pathogens. Interpretation of detection of opportunists in lower respiratory tract
samples remains difficult, even in ill animals, because, even with very strict clinical
case definitions, Pasteurellaceae can also be cultured from the lower airways in healthy
Table 4
Overview of possible culture results for respiratory samples from cattle
Observation Interpretation Explanation
Negative
culture
No growth
Pure culture Abundant growth of a single bacterial species
Dominant
culture
Abundant growth of 1 bacterial species combined
with a limited number of colonies from other
bacteria (contaminants)
Mixed culture Equal growth of 2 bacterial species
(primary or secondary pathogens)
Polymicrobial
culture
Growth of multiple bacterial species (and possibly
molds), of which the most dominant ones
are considered apathogenic for the host
(contaminants or apathogenic flora)
All cultures are on Columbia blood agar and derived from nonendoscopic bronchoalveolar lavage
samples.
Images courtesy of Dr. L. Van Driessche, PhD, Merelbeke, Belgium.
Pardon & Buczinski438animals.10,14 Previously explored ways to overcome the issue of interpreting detection
of opportunistic pathogens in humans and other species are the use of quantitative cul-
tures or cytologic evidence of inflammation. Quantitative culture is derived from the
assumption that, in case of a severe infection, the opportunistic pathogen will be pre-
sent in larger numbers.50 Cutoffs such as greater than 103 colony-forming units per milli-
liter of BAL fluid have been suggested in dogs and horses.20,55 However, pathogen
burden builds up, and sampling early in the disease process could mean that much
lower numbers are detected despite the pathogen being involved in the inflammatory
process.56 Another option is derived from the assumption that a bacterial infection
will result in a massive airway neutrophilia.55 However, clear cutoff percentages for neu-
trophilia differentiating a bacterial infection from a viral one or a strictly noninfectious
airway inflammation have not been determined in calves. Given that some BAL tech-
niques result in a larger contribution of the bronchial component in the total BAL fluid,
BRD Diagnosis 439the neutrophil percentage is increased comparedwith a larger volume of mainly alveolar
lavage fluid.21 Primary insights in calf BAL fluid analysis show that cytologic parameters
coincide poorly with clinical or ultrasonographical findings or culture results for oppor-
tunistic pathogens, at least when using nBAL.57 The presence of phagocytosis by bac-
teria in neutrophils or macrophages may be helpful to differentiate active infection
versus simple presence of the bacteria.57 Although interpreting culture results for oppor-
tunistic pathogens is already difficult, interpretation of PCR results is even more so. Not
only can insignificant quantities or even dead bacteria result in a positive PCR, the nasal
passages also pick up bacterial DNA, making the lower respiratory tract sample posi-
tive. Quantitative PCR might overcome this issue, but, to the authors’ knowledge, no
guidelines on how to interpret these results are currently available in the bovine species.
Sampling Strategy
Although laboratory costs are fixed, the return on investment of an analysis greatly de-
pends on selection of appropriate animals to sample and on the technical sampling
skills of the veterinarian. An animal in the first days of the disease, not previously
treated with antimicrobials and not displaying severe respiratory signs, is first choice.
By sampling in the acute phase of the disease, the odds of detecting the viral compo-
nent are higher. By avoiding previous antimicrobial treatment and by sampling early in
the disease course, the probability that the antibiogram derived is useful for empiric
therapy increases. By avoiding sampling animals in heavy respiratory distress, the
odds of aggravation of disease or even mortality can be decreased.
In addition, in spite of all reasoningmade earlier, veterinarians still make decisions at
an individual animal level. When sampling an individual, the main interest is usually to
make a decision representing the group, and to judge the utility of the diagnostic test
to support this group decision. Different epidemiologic approaches are possible to
determine an appropriate sample size. The goal is more a detection of disease
approach (being 95% confident that the pathogen was detected when present) rather
than determining the prevalence of the pathogen in a group of animals. In the field, sam-
ple size is currentlymore drivenby practical reasons such as available time to sample or
maximum samples allowed to pool for economic reasons. For example, performing
PCR on pools of 5 animals increases sensitivity without diluting the sample too much.
Fig. 2 provides an overview on the risk of not finding a positive animal in 2 scenarios,
1 related to 100%prevalence of thepathogen in thediseasedpopulation and1 scenario
with a pretest probability that 70%of sick calves are affectedby thepathogen (ie,where
multiple pathogens are involved and can cause the same clinical disease). Results of a
test with 70% sensitivity (ie, detects the pathogen in 7 of 10 infected calves) and 100%
specificity (no false-positive calves) are presented. Using this test in a scenario with
70% of the affected animals being positive for the pathogen, after 5 calves not finding
a positive, will misclassify only 3.5% of the herds (the 2 scenarios assume that the
pooled tests’ accuracy is the same as the individual test). In the case of opportunistic
pathogens, given that they can be found in healthy or subclinical animals, at this time
it might bemost prudent to only sample animalswith evidence of clinical bronchopneu-
monia by using a combination of clinical scoring and thoracic ultrasonography.57
Focusing on bacterial isolation to direct intervention strategies, without taking the clin-
ical status into account, holds great danger for overtreatment with antimicrobials.CONCLUDING REMARKS
Knowledge of respiratory health is rapidly evolving in animals, following new develop-
ments in humans. In particular, better insights into the role of the respiratory
Fig. 2. Risk (probability ranging between 0 and 1) of not finding a positive animal for a
given pathogen according to sample size (x axis) in a scenario where 100% (solid line)
and 70% (dashed line) of affected animals are positive for a given pathogen. The graph rep-
resents a test with 70% sensitivity and 100% specificity. It assumes that there are no false-
positive results (ie, when the test indicates that the pathogen is present, this is a true-
positive result). In the example where the pathogen is causing the disease in 100% of
affected calves, the risk of not finding an infected animal after sampling n cases is (1-Se)^
n, where Se is the test sensitivity. In the alternative scenario where only 70% of cases are
caused by the pathogen (ie, in 30% of cases, this is another cause), the probability of not
finding a case is (1–0.7*Se)^ n.
Pardon & Buczinski440microbiome and the interaction of the airway inflammatory response with different or-
ganisms and air pollutants are likely to change how the diagnostic tests discussed in
this article are interpreted. The authors hope that the information, tools, and provi-
sional advice provided can aid the large group of cattle veterinarians, already having
to make rational treatment decisions today.
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